Find verified Retatrutide API manufacturers, suppliers, and distributors across the globe. Explore companies that offer high-purity Retatrutide for pharmaceutical use, along with product details, certifications, and reliable sourcing options. Compare prices, check availability, and connect directly with trusted suppliers for Retatrutide API.
Alternate Names: EX-A7826E, GTPL13769
CAS No: 2381089-83-2
Mol Formula: C221H342N46O68
Mol Weight: 4731 g/mol
IUPAC Name: 20-[[(1S)-4-[2-[2-[2-[[(5S)-5-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3R)- -Show More
API Description: Retatrutide (LY3437943) is an experimental peptide drug developed by Eli Lilly, designed as a triple agonist targeting three key metabolic receptors: GLP-1R (glucagon-like peptide-1 receptor), GIPR (glucose-dependent insulinotropic peptide receptor), and GCGR (glucagon receptor). This combination aims to enhance weight loss and improve metabolic health more effectively than existing treatments.
